Evidence map›Paper›PMID 40692712›Full record

ArticleFrontiers in genetics2025

Integrating genome and transcriptome analysis to decipher balanced structural variants in unsolved cases of neurodevelopmental disorders.

Simona Mellone, Alice Spano, Denise Vurchio, Giulia Borgonovi, Alessandro Ugonotti, Giulia Paglino, Alba Bianco, Sara Ronzani, Maurizio Sciancalepore, Flavia Prodam and 4 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Simona Mellone *Unit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Alice Spano *Unit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Denise VurchioUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Giulia BorgonoviUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Alessandro UgonottiUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Giulia PaglinoUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Alba BiancoUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Sara RonzaniUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Maurizio SciancaleporeUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Flavia ProdamDepartment of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
Amanda PapaDepartment of Child Neuropsychiatry, University Hospital "Maggiore della Carità", Novara, Italy.
Maurizio ViriDepartment of Child Neuropsychiatry, University Hospital "Maggiore della Carità", Novara, Italy.
Umberto DianzaniUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.
Mara GiordanoUnit of Genetics, Clinical Biochemistry, University Hospital "Maggiore della Carità", Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Balanced chromosomal abnormalities (BCAs) are structural variations that can underlie a wide spectrum of neurodevelopmental disorders, often remaining undetected by conventional diagnostic approaches. Whole-genome sequencing (WGS) allows for base-pair resolution of structural variants across the entire genome, making it a powerful tool to detect cryptic chromosomal rearrangements and refine breakpoint mapping. RNA sequencing (RNA-Seq), by enabling the detection of gene expression changes and fusion transcripts, provides complementary functional insights into the consequences of genomic alterations. This study integrated WGS and RNA-Seq to precisely characterize the breakpoints and assess the functional impact of Materials and methods: Short read WGS was used to identify the chromosomal breakpoints and gene disruptions caused by BCAs. RNA-Seq on blood RNA was employed to detect differential gene expression and potential fusion transcripts of disrupted genes. Results: In the first case, the inversion inv(8) (p11.2q13) disrupted two genes at the breakpoints, namely, Conclusion: These findings highlight the crucial role of WGS in identifying disease-associated BCAs and underscore the complementary value of RNA-Seq in assessing their functional consequences. This integrated approach enhanced diagnostic accuracy and clinical management, paving the way for more comprehensive and personalized care in these two patients.

Indexed as

balanced chromosomal abnormalitiesCHD7EP300neurodevelopmental disordersRBFOX3SLC20A2

Identifiers

PMID40692712
PMCPMC12277603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.